Atea Pharmaceuticals, Inc. (AVIR)
NASDAQ: AVIR · Real-Time Price · USD
4.460
+0.300 (7.21%)
At close: Feb 11, 2026, 4:00 PM EST
4.460
0.00 (0.00%)
Pre-market: Feb 12, 2026, 7:00 AM EST

Atea Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
3482832544017433,452
Market Cap Growth
33.08%11.19%-36.48%-46.08%-78.48%-
Enterprise Value
20-198-338-261-963,522
Last Close Price
4.463.353.054.818.9441.78
PE Ratio
----6.13-
PS Ratio
----2.1170.97
PB Ratio
1.100.650.460.631.056.30
P/TBV Ratio
1.100.650.460.631.056.30
P/FCF Ratio
-----11.63
P/OCF Ratio
-----11.63
EV/Sales Ratio
-----72.42
EV/FCF Ratio
-----11.87
Debt / Equity Ratio
0.000.000.000.010-
Debt / EBITDA Ratio
----0.00-
Asset Turnover
----0.430.11
Quick Ratio
16.3224.4418.0435.0013.442.71
Current Ratio
16.6624.8518.2435.7713.582.73
Return on Equity (ROE)
-37.98%-33.88%-22.74%-17.16%19.27%-3.86%
Return on Assets (ROA)
-23.86%-15.60%-11.94%-9.65%10.57%-1.56%
Return on Capital Employed (ROCE)
-49.30%-29.60%-21.40%-17.10%19.30%-2.00%
Earnings Yield
-42.19%-59.51%-53.42%-28.93%16.31%-0.32%
FCF Yield
-38.52%-47.89%-33.56%-30.68%-11.71%8.60%
Buyback Yield / Dilution
1.10%-1.05%-0.17%5.67%-308.70%-113.98%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q